Heerlen, NL, 27 Sep 2012 08:15 CEST
Royal DSM, the global Life Sciences and Materials Sciences company, will today and tomorrow update the financial community at its annual Capital Markets Days on progress made with its DSM in Motion: driving focused growth strategy.
Feike Sijbesma, CEO and Chairman of the DSM Managing Board, said: “While we remain cautious on the near-term macro-economic outlook, the robustness of our portfolio reinforces our confidence that DSM’s strategic focus will continue to create value for shareholders and other stakeholders. Our recent acquisitions demonstrate that we are delivering on our strategy by investing in new, exciting growth opportunities. We continue to execute our strategy to achieve stronger, more stable growth and profitability for DSM overall. We are leveraging our geographic footprint with our strong position in high growth economies, while developing sustainable innovative solutions that address key global megatrends.”
During the two-day conference in Basel, Switzerland, DSM will update the investment community on progress made with its strategic plans announced in 2010: DSM in motion: driving focused growth. This growth strategy marks the shift to an expanded portfolio of higher value businesses and a more attractive geographic spread, to create value by providing solutions for compelling long-term megatrends.
The following will be discussed today:
On Friday, the presentations will be entirely dedicated to DSM’s Nutrition activities in order to provide deeper insights into these businesses and their value drivers.